Aarey Drugs & Pharmaceuticals Limited (AAREYDRUGS) Share Price
NSE · Healthcare · Drug Manufacturers - Specialty & Generic · ISIN INE198H01019
Key metrics
- Market Cap
- ₹297 Cr
- P/E Ratio
- 70.09
- EPS
- 1.27
- Book Value
- 53.05
- P/B Ratio
- 1.64
- ROE
- 2.64%
- ROCE
- 2.16%
- Debt / Equity
- 0.33
- Net Margin
- 0.84%
- Revenue Growth
- -0.35%
- Profit Growth
- -1.4%
- Dividend Yield
- —
- 52W High
- ₹100.00
- 52W Low
- ₹50.31
- Market Cap Band
- micro cap
- Face Value
- —
Ratios computed from the annual results period ending 2026-03-31.
About Aarey Drugs & Pharmaceuticals Limited
Aarey Drugs & Pharmaceuticals Limited manufactures and sells active pharmaceutical ingredients, intermediates, and specialty chemicals for various industrial applications in India. The company offers intermediates, including mono methyl urea, di methyl urea, ortho para nitro anisole, 2-bromomethyl-1,3-dioxolane, and uracil. It also provides active pharmaceutical ingredients, such as metformin HCl, mefenamic acid, and doxofylline. In addition, the company trades chemicals and solvents, including aromatic chemicals, chemical acids, chlor-alkali, glycols and glycol ethers, fiber intermediates, and acetates and esters, as well as industrial alcohols, ketones, amines, oleochemicals, intermediates, olefins, phosphates, fertilizers, monomers, and chemicals. It serves pharmaceutical formulation manufacturers and pharmaceutical merchant exporters. Aarey Drugs & Pharmaceuticals Limited was incorporated in 1990 and is headquartered in Mumbai, India.
- Headquarters
- Mumbai, India
- Promoter Holding
- 43.18%
The full Aarey Drugs & Pharmaceuticals Limited analysis
Create a free account to open the complete AAREYDRUGS deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.